Serum Heparanase Level Is Decreased in Stable Coronary Artery Disease

OBJECTIVE: Heparanase (HPA), mammalian endo-β-D-glu­cu­ronidase, separates heparan sulfate chains of proteoglycans and changes the structure of the extracellular matrix. We investigated whether serum levels of HPA differ in patients with stable coronary artery disease (SCAD) and subjects with normal...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Med Princ Pract
Autori principali: Gurbuz, Ahmet Seyfeddin, Ozturk, Semi, Efe, Suleyman Cagan, Yilmaz, Mehmet Fatih, Yanik, Raziye Ecem, Yaman, Ali, Kirma, Cevat
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2019
Soggetti:
Original Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944950/
https://ncbi.nlm.nih.gov/pubmed/31480068
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000503085
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi